Results Out of 116,235 GLP-1RA users and 217,668 DPP4i users, we propensity score-matched 80,948 pairs, on 88 characteristics
Ahmann AJ, Capehorn M, Charpentier G et al (2018) Efficacy and safety of once-weekly semaglutide versus exenatide ER in subjects with type 2 diabetes (SUSTAIN 3): a 56-week, open-label, randomized clinical trial
Its Body Program combines FDA-approved GLP-1 medications, such as Wegovy or Zepbound, with one-on-one health coaching, progress tracking tools, and lifestyle support
While all GLP-1 drugs influence appetite and metabolism, only some (like semaglutide and tirzepatide) are FDA-approved specifically for weight management
Plan ahead for airport security, hotel refrigerators, and time zone changes that may affect your dosing schedule
D.EvansJ